Cabela’s Reiterated as Top Pick and 4 Stock Analyses to Know Now
Aegerion Pharmaceuticals, Inc.’s (NASDAQ:AEGR) label for Aegerion’s Juxtapid is seen by JPMorgan as being positive, and it keeps its Overweight rating on the stock following FDA approval of the drug. The firm has increased its price target to $30 from $28 on the stock.
Mosaic Co. (NYSE:MOS): According to Goldman, Mosaic shares should be purchased on any weakness after the company’s Q2 report on January 4. The firm views challenging fundamentals as being understood by investors and believes that 2013 possesses visible catalysts, including new China/India contracts in Q1 and margin opportunities in Phosphates. Shares have a Buy rating and a $68 price target.
Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.
Cabela’s Inc. (NYSE:CAB) continues to be a top pick at Northland considering the company’s top line and bottom line growth, upside from its online business, and potential to beat its 2013 EPS estimate of $3.00. Shares have an Outperform rating.
Rackspace Hosting, Inc (NYSE:RAX): Piper Jaffray has stated that over the last few months, Hewlett-Packard (NYSE:HPQ) launched a number of new cloud services as Dell (NASDAQ:DELL) continued to increase its cloud development. Piper has claimed that as the new services caused investor concern, it does not believe that the new products pose an immediate or even medium-term threat to Rackspace’s (NYSE:RAX) cloud growth. The firm has reiterated its Overweight rating on the stock.
Callidus Software Inc. (NASDAQ:CALD): Northland’s checks have shown that there is a strong ICM market possessing healthy customer demand with purchases towards broader product suite purchases. The firm continues to think that Callidus is in a good position heading into 2013, and it keeps its Outperform rating and $8 price target.
Investing Insights: Will Cummins Continue to Motor Higher?